Insights on Switching Anti-VEGF Agents for Optimal AMD Treatment
Highlights of a roundtable discussion held during the 2013 meeting of the Association for Research in Vision and Ophthalmology (ARVO)
![]() |
Peter Kaiser, MD, (Moderator) is the Chaney Family Endowed Chair in Ophthalmology Research at the Cleveland Clinic Lerner College of Medicine. |
Justis Ehlers, MD is an assistant professor at Cole Eye Institute at the Cleveland Clinic Lerner College of Medicine. |
![]() |
![]() |
Seenu Hariprasad, MD is the chief of the Vitreoretinal Service at the University of Chicago, where he is an associate professor. |
Atul Jain, MD is a partner at San Diego Retina Associates, where he specializes in vitreoretinal surgery. |
![]() |
![]() |
Jason Slakter, MD is a practicing retinal specialist in New York City, a clinical professor of ophthalmology at NYU School of Medicine and the director of the Digital Angiography Reading Center. |